Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Impact of thyroid dysfunction on serum cystatin C.

Manuel Fricker1, Peter Wiesli, Michael Brändle

  • 1Department of Internal Medicine, Division of Endocrinology and Diabetes, University Hospital of Zurich, Zurich, Switzerland.

Kidney International
|April 5, 2003
PubMed
Summary

Serum cystatin C (CysC) levels are affected by thyroid dysfunction, unlike creatinine. CysC is lower in hypothyroidism and higher in hyperthyroidism, impacting its use as a kidney function marker.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of Leukemic Blood Samples with Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Is Associated with Reduced Frequencies of Tolerogenic Dendritic Cells and Increased Cytotoxicity Against Autologous Blasts.

Biomedicines·2026
Same author

Longitudinal variability of lipoprotein(a) in youth-onset type 1 diabetes: implications for cardiovascular risk stratification.

Cardiovascular diabetology·2026
Same author

Patients with type 1 diabetes mellitus and recommended low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B targets - a SwissDiab study.

Frontiers in endocrinology·2026
Same author

Performance of Seven-Gene Panel Testing for Risk Stratification of Thyroid Nodules with Indeterminate Cytology Results.

International journal of molecular sciences·2026
Same author

Digital Quality Monitoring for Type 2 Diabetes in Swiss Primary Care: Qualitative Interview Study.

Journal of medical Internet research·2026
Same author

A care quality dashboard for general practitioners managing patients with diabetes mellitus type 2: user-centered design and prototype evaluation.

BMC medical informatics and decision making·2026

Area of Science:

  • Endocrinology
  • Nephrology
  • Clinical Chemistry

Background:

  • Serum cystatin C (CysC) is a kidney function marker.
  • Thyroid dysfunction can alter serum creatinine levels.
  • This study investigates CysC and creatinine changes during thyroid dysfunction treatment.

Purpose of the Study:

  • To evaluate if CysC and creatinine levels change in parallel during thyroid dysfunction treatment.
  • To determine the impact of hypo- and hyperthyroidism on CysC and creatinine.
  • To assess the clinical relevance of CysC as a kidney function marker in thyroid disease.

Main Methods:

  • Prospective case series of 22 patients with thyroid dysfunction.
  • Measured serum creatinine and CysC at diagnosis and after thyroid function normalization.

Related Experiment Videos

  • Patients received levothyroxine for hypothyroidism or antithyroid treatment for hyperthyroidism.

    • Main Results:

    • In hypothyroidism, creatinine decreased (P=0.062) while CysC increased (P<0.001).
    • In hyperthyroidism, creatinine increased (P=0.004) while CysC decreased (P<0.001).
    • CysC levels were significantly altered in both hypo- and hyperthyroid states.

    Conclusions:

    • Thyroid dysfunction significantly impacts serum CysC levels.
    • CysC is lower in hypothyroidism and higher in hyperthyroidism compared to euthyroid states.
    • Thyroid function must be considered when interpreting CysC as a marker of kidney function.